Document is current
Any future updates will be listed below
-
Authors
He, Shijun
Liu, Xing
Lin, Zemin
Liu, Yuting
Gu, Lei
Zhou, Hu
Tang, Wei
Zuo, Jianping
-
Funding
Funding for this research was provided by:
Personalized Medicines——Molecular Signature-based Drug Discovery and Development Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12020107)
Personalized Medicines——Molecular Signature-based Drug Discovery and Development Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12020215)
The National Basic Research Program of China (2014CB541906)
National Natural Science Foundation of China (81402939)
- License Information
-
More Information
Article History
Received: 2 August 2018
Accepted: 11 January 2019
First Online: 29 January 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
